Aleem Ahmed Khan completed his PhD in Biotechnology and currently serves as Head of the Department at Deccan College of Medical Sciences, Owaisi Hospital and Research Centre, Hyderabad, India. He has published over 300 research articles in reputed international journals with more than 10,219 citations, an h-index of 41, and an i10-index of 165. He has authored 20 book chapters and holds 7 patents. His research spans neuroscience, molecular biology, mitochondrial dysfunction, stem cells, drug discovery, genetics, omics, liver cirrhosis, and ulcerative colitis. His pioneering work includes the development of Neo-artificial functional humanized liver organs for liver failure patients, Neo-pancreatic β-cell organs for diabetes treatment, nanoparticle-based stem cell tracking and delivery, and 3D culture model systems for cancer drug resistance. He has also advanced translational approaches such as trans-differentiated β-cell transplantation in diabetes and model systems for studying regeneration in alcohol-induced damage. He is an active reviewer and editorial board member for several high-impact journals. His innovative contributions in stem cell research, regenerative medicine, nanotechnology, and Bioartificial organ development have significantly advanced understanding and therapeutic strategies for neurodegenerative diseases, metabolic disorders, and cancer.